Investigating the clinical significance of immune and thyroid biomarkers in women with breast cancer and Hashimoto's thyroiditis
Reproductive Biology · 2025
DOI: 10.1016/j.repbio.2025.101011 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive Biology, 2025. Verfasst von Israa Khalaf Aneed und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Mustansiriyah University, College of Science, Baghdad, Iraq. Electronic address: israa.k.h@uomustansiriyah.edu.iq. Hauptthemen laut MEDLINE: Breast Neoplasms, Hashimoto Disease. Die Arbeit nennt 80 Literaturangaben. Gefördert von: Mustansiriyah University.
Abstract (Originalsprache)
Breast cancer with Hashimoto's thyroiditis (BC-HT) presents a unique immuno-thyroid interplay that remains poorly understood. This study investigates the relationships between thyroid function markers (TSH, T3, T4), immune markers (CD33, CD44), and thyroid autoantibodies (Anti-TPO, Anti-Tg) in BC-HT patients and healthy controls. Normality testing confirmed non-parametric data distribution, necessitating Mann-Whitney U tests for group comparisons. BC-HT patients exhibited significantly elevated TSH, CD33, Anti-TPO, and Anti-Tg levels, alongside reduced T3 and T4, compared to controls, indicating thyroid dysfunction. Spearman's correlation analysis revealed strong negative correlations between TSH and T3/T4 in controls, which were lost in BC-HT, suggesting disruption of normal thyroid feedback mechanisms. Additionally, CD33 and CD44 correlations with thyroid hormones were evident in controls but absent in BC-HT, highlighting altered immune-thyroid interactions. ROC analysis demonstrated high diagnostic performance for TSH, Anti-Tg, and Anti-TPO, with sensitivities exceeding 0.75, whereas CD33 and CD44 showed limited diagnostic utility. These findings suggest a distinct immuno-thyroid dysregulation in BC-HT patients and highlight the potential of thyroid-specific markers for disease stratification. Future research should focus on longitudinal studies and mechanistic investigations to further delineate the role of immune markers in breast cancer pathophysiology within the context of thyroid autoimmunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Mustansiriyah University, College of Science, Baghdad, Iraq. Electronic address: israa.k.h@uomustansiriyah.edu.iq.
- Department of Biology, Mustansiriyah University, College of Science, Baghdad, Iraq.
- National center for medical laboratories, Medical City, Ministry of Health, Baghdad, Iraq.
Förderung
- Mustansiriyah University
Zitieren
APA
Aneed, I. K., Luaibi, N. M., & Abdulqader, S. N. (2025). Investigating the clinical significance of immune and thyroid biomarkers in women with breast cancer and Hashimoto's thyroiditis. Reproductive Biology. https://doi.org/10.1016/j.repbio.2025.101011
Vancouver
Aneed IK, Luaibi NM, Abdulqader SN. Investigating the clinical significance of immune and thyroid biomarkers in women with breast cancer and Hashimoto's thyroiditis. Reproductive Biology. 2025. doi:10.1016/j.repbio.2025.101011
BibTeX
@article{Aneed2025,
author = {Aneed, Israa Khalaf and Luaibi, Noori Mohammed and Abdulqader, Sajid Nader},
title = {Investigating the clinical significance of immune and thyroid biomarkers in women with breast cancer and Hashimoto's thyroiditis},
journal = {Reproductive Biology},
year = {2025},
doi = {10.1016/j.repbio.2025.101011}
}
EUVIMED